APREA THERAPEUTICS, INC. (APRE): Price and Financial Metrics
APRE Price/Volume Stats
| Current price | $3.01 | 52-week high | $8.85 |
| Prev. close | $3.02 | 52-week low | $2.15 |
| Day low | $2.87 | Volume | 12,000 |
| Day high | $3.12 | Avg. volume | 20,230 |
| 50-day MA | $3.33 | Dividend yield | N/A |
| 200-day MA | $4.59 | Market Cap | 16.36M |
APRE Stock Price Chart Interactive Chart >
APREA THERAPEUTICS, INC. (APRE) Company Bio
Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Aprea Therapeutics serves customers in the United States and Sweden.
APRE Price Returns
| 1-mo | -27.99% |
| 3-mo | -14.25% |
| 6-mo | -43.20% |
| 1-year | -18.21% |
| 3-year | -96.26% |
| 5-year | -99.41% |
| YTD | -35.96% |
| 2023 | -29.00% |
| 2022 | -88.47% |
| 2021 | -41.67% |
| 2020 | -89.28% |
| 2019 | N/A |
Loading social stream, please wait...